Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torsemide ER vs Furosemide in CHF Patients
NCT03509545Phase 1Terminated
- Start
- Jun 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of torasemide in heart failure (HF) (2 arms). Primary endpoint: Change in 24-hour sodium excretion. Started Jun 2021; status: terminated.
02
Drugs
torasemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03509545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03509545.